Section Arrow
Quote
CVKD.NASDAQ
- Cadrenal Therapeutics Inc
Quotes are at least 15-min delayed:2024/12/24 12:21 EST
Last
 14.57
+0.31 (+2.17%)
Day High 
14.77 
Prev. Close
14.26 
1-M High
18 
Volume 
33.55K 
Bid
14.35
Ask
14.68
Day Low
13.77 
Open
14.47 
1-M Low
10.2 
Market Cap 
23.65M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 12.83 
20-SMA 13.26 
50-SMA 14.78 
52-W High 32.55 
52-W Low 5.4 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.73/-2.84
Enterprise Value
23.65M
Balance Sheet
Book Value Per Share
2.06
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.3931-0.01-2.48%-- 
CMNDClearmind Medicine1.655+0.435+35.66%0.16PE
CEROCERo Therapeutics Holdings0.05945+0.00895+17.72%-- 
RXRXRecursion Pharmaceuticals7.215+0.225+3.22%-- 
CDTConduit Pharmaceuticals0.06+0.0055+10.09%-- 
Quotes are at least 15-min delayed：2024/12/24 12:21 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.